超声用于客观测量乳腺淋巴水肿
研究纳入30例接受保乳手术、前哨淋巴结活检和放疗的浸润性乳腺癌患者及10例对照,以超声测量患侧与健侧皮肤厚度差来定义乳腺淋巴水肿(>0.3 mm),结果显示该测量方法简便、廉价,且与手术因素、放疗因素及患者报告的生活质量影响相关。
要点
- 超声测量患侧与健侧皮肤厚度差>0.3 mm可定义乳腺淋巴水肿。
- 浸润性乳腺癌患者中63%符合该定义的乳腺淋巴水肿。
- 皮肤厚度差与手术、放疗参数及患者报告的生活质量影响相关。
核心结论
- 皮肤厚度差是一种简便、廉价的乳腺淋巴水肿定量测量方法,并与治疗参数及患者报告的生活质量影响相关。
研究设计与样本
- 研究纳入30例接受保乳手术、前哨淋巴结活检和放疗的浸润性乳腺癌患者及10例无乳腺手术或放疗史、因良性乳腺情况评估的对照患者;患者与治疗变量来自病历和放疗记录,生活质量影响采用改良版上肢、肩和手功能障碍问卷测量;采用对数二项回归模型量化关联。
关键影像表现/征象
- 以超声测量患侧与健侧皮肤厚度差来表征乳腺淋巴水肿。
- 乳腺淋巴水肿定义为皮肤厚度差>0.3 mm。
- 浸润性乳腺癌组中19例(63%)符合该定义的乳腺淋巴水肿。
诊断标准与关键数值
- 乳腺淋巴水肿的超声定义为患侧与健侧皮肤厚度差>0.3 mm。
- 按此定义,浸润性乳腺癌组中19例(63%)存在乳腺淋巴水肿。
临床应用与阅片要点
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: Breast lymphedema has supplanted upper extremity lymphedema as a common and debilitating sequela of breast cancer treatment, but has no objective measurement. We assessed the utility of ultrasound-measured difference in dermal thickness between affected and unaffected breasts as a measure of breast lymphedema. We associated this measure with patient characteristics, treatment parameters, and patient-reported impact on quality of life.
METHODS: We enrolled 30 invasive breast carcinoma patients treated with breast-conserving surgery, sentinel lymph node biopsy, and radiotherapy, and 10 control patients evaluated for benign breast conditions without prior breast surgery or radiotherapy. Patient and treatment variables were ascertained from medical records and radiotherapy instruments. Impacts on quality of life were measured with a modified Disability of the Arm, Shoulder, and Hand questionnaire. We characterized breast lymphedema by calculating the difference in ultrasound-measured dermal thickness between affected and unaffected breasts. Associations with patient characteristics, treatment, and quality of life were quantified with log-binomial regression models.
RESULTS: Breast lymphedema was defined as a dermal thickness difference of >0.3 mm. Nineteen patients in the invasive group (63%) had breast lymphedema by this definition. We observed positive associations between ultrasound-defined breast lymphedema and surgical factors (size of primary tumor, number of lymph nodes removed), radiotherapy factors (breast volume irradiated, receipt of radiation boost), and patient-reported outcomes (sleep quality and overall confidence).
CONCLUSIONS: Difference in dermal thickness is an easy and inexpensive measurement for quantifying breast lymphedema, and correlates with treatment parameters and patient-reported impacts on quality of life.
引用
- Kerrigan, Ahern, Brennan, et al. Ultrasound for the Objective Measurement of Breast Lymphedema. J Ultrasound Med. 2021. PMID: 34792209. doi:10.1002/jum.15881
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。